Mesoblast's FDA approval for remestemcel marks a milestone for MSC therapies, but limited cash reserves pose risks for US ...

"Federal law requires defendants to ensure that their drug labels remain accurate, and when new scientific information ...

After a years-long complex turnaround project, Cell C appears to be in the early stages of recovery from a dire financial ...

FDA could strengthen labeling requirements for plant- and cell-based products to ensure consumers understand how their nutrition and production compare to that of their animal-based counterparts ...

Nutrition Facts labels provide useful information about how nutritious a food is, but can be overwhelming. A single score ...

This important study describes a first-in-human trial of autologous p63+ stem cells in patients with idiopathic pulmonary fibrosis, a lethal condition for which effective treatments are lacking. The ...

This important study leverages the power of Drosophila genetics and sparsely-labeled neurons to propose a new model for neuronal injury signaling. The authors present convincing evidence to support ...

Dongguk Universitys Kim Kyo-beom advances NK cell cancer therapy with Selvascan Selvascan pioneers immune cell innovation to ...

Bristol-Myers Squibb has rebounded strongly in 2024, driven by key drug approvals and positive financial performance. See why ...

The word “inflammation” has become increasingly popular over the last few years. Inflammation connects with serious health ...